THE CELLFINA SYSTEM CK-1 5036030

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a other report with the FDA on 2019-05-09 for THE CELLFINA SYSTEM CK-1 5036030 manufactured by Ulthera, Inc., Merz Device Innovation Center.

Event Text Entries

[144595106] Attempts to contact the doctor to gather additional information regarding the event and if a device malfunction occurred during treatment were performed on (b)(6) 2019, (b)(6) 2019, and (b)(6) 2019; however, no additional information was provided. A review of the shipping history indicated multiple cellfina systems were shipped to this customer, but it is unknown what device was used during treatment on this patient. As information linking the alleged scarring to a particular device, kit, or malfunction is not possible, device identification and evaluation cannot be performed. A review of the patient complaint trend analysis for the reported issue of "scar" found this condition has not occurred at a high enough frequency level to provide a signal at this time and will continue to be monitored. Although the initial information for this event was provided directly from the patient who received treatment, the treating office is listed as they were the appropriate contact for follow-up. Should additional information regarding this event become available, a supplemental medwatch will be filed.
Patient Sequence No: 1, Text Type: N, H10


[144595107] A patient alleged on (b)(6) 2019 that six months following cellfina treatment, she had 34 dark scars on the treatment spots of her buttocks and thighs. The patient attributed it to her skin type and alleged informing the doctor that her skin scars differently, but was reassured that the procedure would not scar. The patient reported having a laser procedure following the cellfina treatment in an attempt to reduce the visibility of the scars, but the scars became worse after the treatment. The patient also reported having previous liposuction performed in the area. The patient does not believe any malfunction occurred or that the procedure went wrong. Attempts to contact the doctor to gather additional information regarding the event occurred on (b)(6) 2019, (b)(6) 2019, and (b)(6) 2019; however, no additional information is available at this time.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3006560326-2019-00008
MDR Report Key8596501
Report SourceOTHER
Date Received2019-05-09
Date of Report2019-04-10
Date Mfgr Received2019-04-10
Date Added to Maude2019-05-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. JESSICA WARD DYKSTRA
Manufacturer Street1840 SOUTH STAPLEY DRIVE SUITE 200
Manufacturer CityMESA AZ 85204
Manufacturer CountryUS
Manufacturer Postal85204
Manufacturer Phone4803361457
Manufacturer G1ULTHERA, INC., MERZ DEVICE INNOVATION CENTER
Manufacturer Street1840 SOUTH STAPLEY DRIVE SUITE 200
Manufacturer CityMESA AZ 85204
Manufacturer CountryUS
Manufacturer Postal Code85204
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTHE CELLFINA SYSTEM
Generic NameCELLFINA SYSTEM
Product CodeOUP
Date Received2019-05-09
Model NumberCK-1
Catalog Number5036030
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerULTHERA, INC., MERZ DEVICE INNOVATION CENTER
Manufacturer Address1840 SOUTH STAPLEY DRIVE SUITE 200 MESA AZ 85204 US 85204


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-05-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.